Octreotide Impurity 12 is a related peptide species formed during octreotide synthesis or degradation. Modifications in residue sequence or protecting-group history alter ring conformation and retention times. Researchers employ it as a reference to refine impurity limits and analytical sensitivity. Applications include QC method validation, stability testing, and structural-variant comparison.
CAT No: R2763
Synonyms/Alias:(R)-1-((2R,3R)-2-((4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamido)-3-hydroxybutoxy)-1-oxopropan-2-yl (R)-2-hydroxypropanoate; L-Lactolactoyl-Thr-Octreotide; Octreotide Impurity 12
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More